Advertisement

Topics

Eli Lilly and Company Company Profile

00:56 EST 18th January 2017 | BioPortfolio

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat <!--LGfEGNT2Lhm-->depression, <!--LGfEGNT2Lhm-->schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. We are committed to providing answers that matter - through medicines and information - for some of the world's most urgent medical needs.

Products for Human Use (published 14th May 2013)

BONE MUSCLE JOINT
Evista® (raloxifene hydrochloride)
Forteo® (teriparatide [rDNA origin] injection)
CARDIOVASCULAR
Adcirca® (tadalafil)
Effient® (prasugrel)
Livalo® (pitavastatin)
DIABETES
Glucagon™ (glucagon for injection [rDNA origin])
Humalog® (insulin lispro injection USP [rDNA origin])
Humalog® Mix50/50™ (50% Insulin lispro protamine suspension, 50% insulin lispro injection [rDNA origin])
Humalog® Mix75/25™ (75% Insulin lispro protamine suspension, 25% insulin lispro injection [rDNA origin])
Humulin® R (U-100) ) (regular insulin human injection, USP [rDNA origin])
Humulin® R (U-500) (regular U-500 [concentrated] insulin human injection, USP [rDNA origin])
Humulin® 70/30 (70 percent human insulin isophane suspension, 30 percent human insulin injection [rDNA origin])
Humulin® N (NPH human insulin [rDNA origin] isophane suspension)
Tradjenta® (linagliptin) tablets**
ENDOCRINE
Humatrope® (somatropin [rDNA origin] for injection)
MEN'S HEALTH
Axiron® (testosterone)
Cialis® (tadalafil)
NEUROSCIENCE
Amyvid™ (Florbetapir F 18 Injection)
Cymbalta® (duloxetine delayed release)
Strattera® (atomoxetine hydrochloride)
Zyprexa®Relprevv™  (olanzapine)
ONCOLOGY
Alimta® (pemetrexed for injection)
Erbitux® (cetuximab)

ANIMAL USE

ELANCO COMPANION ANIMAL HEALTH
Assurity ®
Comfortis ®
Reconcile ®
Trifexis ®

ELANCO FOOD SOLUTIONS
Coban ®
Component ®
Component wiTh Tylan Implants ®
Elector Bait ®
Elector PSP ®
HeifermaX 500 ®
Keto-Test ®
Long-Acting Implants ®
Maxiban ®
Micotil ®
Monteban ®
Optaflexx ®
Paylean ®
Posilac ®
Pulmotil ®
Rumensin ®
StandGuard Pour-On ®
StanGuard Premise ®
Topmax ®
Tylan ®
Tylan Injection ®
Tylan Soluble ®
Tylan Sulfa-G ®

Lilly(TM) is a registered trademark of Eli Lilly and Company.  BioPortfolio's use of the Lilly(TM) trademark on this site does not imply any affiliation with or endorsement by Eli Lilly and Company.  If you are looking for Eli Lilly and Company's official website, please visit www.lilly.com.

Location

Lilly Corporate Center
Indianapolis
Indiana
46285
United States of America

Contact

Phone: +1-317-276-2000
Fax: 317 276 2095


News Articles [836 Associated News Articles listed on BioPortfolio]

Eli Lilly and Company Strategy, SWOT and Corporate Finance Report Prices from USD $175

SummaryEli Lilly and Company Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi...

Lilly Declares Fourth-Quarter 2016 Dividend

INDIANAPOLIS, Oct. 17, 2016 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2016 of $0.51 per share on outstanding co...

Lilly Confirms Date And Conference Call For Third-Quarter 2016 Financial Results Announcement

INDIANAPOLIS, Oct. 4, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the third quarter of 2016 on Tuesday, October 25, 2016. Lilly will also conduct a c...

Zymeworks hits another research milestone in bi-specific antibody collaboration with Eli Lilly

VANCOUVER, BC- Zymeworks Inc. reports it has successfully achieved another research milestone in its collaboration with Eli Lilly and Company (Lilly) using Zymeworks’ proprietary Azymetric™ platfo...

Lilly Confirms Date and Conference Call for 2017 Financial Guidance Announcement

INDIANAPOLIS, Dec. 2, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2017 and provide updated financial guidance for 2016 on Thursday, December 15...

Figure: Lilly's launch pad

Lilly's history lesson Lilly's launch pad During John Lechleiter's tenure as president and CEO Eli Lilly and Co. (NYSE:LLY) will have launched 10 drugs. Seven of these will be three years old or less,...

Eli Lilly and Company: Es gibt Hoffnungsträger, doch…

Eli Lilly & Co., mit Sitz in Indianapolis, gehört zu den zehn größten Pharmaunternehmen der Welt. Der Konzern entwickelt, produziert und vermarktet Arzneimittel zur Behandlung von Depressionen, Sch...

Lilly to Participate in Credit Suisse 2016 Healthcare Conference

INDIANAPOLIS, Oct. 11, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Credit Suisse 2016 Healthcare Conference on Monday, November 7, 2016. The following Lilly exe...

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Xigris [Eli Lilly and Company]

These highlights do not include all the information needed to use XIGRIS safely and effectively. See full prescribing information for XIGRIS.XIGRIS (drotrecogin alfa (activated)) injection, powder, ly...

Axid ar [Wyeth Consumer Healthcare]

Axid AR (nizatidine)

Gemzar [Eli Lilly and Company ]

These highlights do not include all the information needed to use GEMZAR safely and effectively. See full prescribing information for GEMZAR.GEMZAR (gemcitabine for injection) Powder, Lyophilized, For...

Humulin [Eli Lilly and Company]

HUMULIN 70/3070% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA ORIGIN)100 UNITS PER ML (U-100)

Humulin [Eli Lilly and Company]

HUMULIN N NPH HUMAN INSULIN (rDNA ORIGIN)ISOPHANE SUSPENSION100 UNITS PER ML (U-100)

PubMed Articles [35 Associated PubMed Articles listed on BioPortfolio]

Upstream solutions for price-gouging on critical generic medicines.

Exorbitant price increases for critical off-patent medicines have received considerable media attention in recent months, leading to an investigation by the U.S. Senate. However, much of this attentio...

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations.

Until recently, estimation of β-amyloid plaque density as a key element for identifying Alzheimer's disease (AD) pathology as the cause of cognitive impairment was only possible at autopsy. Now with ...

The Proximal Lilly Collection: Mapping, Exploring and Exploiting Feasible Chemical Space.

Venturing into the immensity of the small molecule universe to identify novel chemical structure is a much discussed objective of many methods proposed by the chemoinformatics community. To this end n...

Poetry's Company: Where Medicine Leaves Us Alone.

The Large Pharmaceutical Company Perspective.

Clinical Trials [27 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen™ (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia ...

Nanoparticles Emitted by Aircraft Engines, Impact on the Respiratory Function:

The object of this new project is to proceed with investigations with the employees of the cohort for the first study so as to obtain a remote evolution (5 years) of their respiratory func...

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the ATU.

Lilly's Emotional and Physical Symptoms of Depression

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Lilly's Emotional and Physical Symptoms of Depression Study

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice-based setting

Companies [70 Associated Companies listed on BioPortfolio]

Lilly USA

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and fro...

EquipNet, Inc

Massachusetts based EquipNet, Inc., has become the world’s largest surplus asset management company. The company offers a range of tools that allow companies to take control of their assets. F...

TerraVia

TerraVia™ (formerly Solazyme®) is a next generation food, nutrition and specialty ingredients company that harnesses the power of algae, the mother of all plants and earth...

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. ...

Pharnext SAS

Pharnext is an advanced clinical stage biopharmaceutical company founded by renowned scientists and entrepreneurs including Professor Daniel Cohen, a pioneer in modern genomics. P...

More Information about "Eli Lilly and Company" on BioPortfolio

We have published hundreds of Eli Lilly and Company news stories on BioPortfolio along with dozens of Eli Lilly and Company Clinical Trials and PubMed Articles about Eli Lilly and Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eli Lilly and Company Companies in our database. You can also find out about relevant Eli Lilly and Company Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Bipolar Disorders
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Over half of Bipolar cases develops before the age of 25. Bipolar ...

Schizophrenia
Schizophrenia is a common  serious long-term mental health condition that affects 5 in 1000 in the UK. It causes a range of different psychological symptoms; hallucinations, delusions, muddled thoughts based on the hallucinations or delusions and ch...


Corporate Database Quicklinks



Searches Linking to this Company Record